Codex DNA, Inc. – NASDAQ:DNAY
Codex DNA stock price today
$1.3
+1.3
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 4 hours
Codex DNA stock price monthly change
-100.00%
month
Codex DNA stock price quarterly change
-100.00%
quarter
Codex DNA stock price yearly change
-100.00%
year
Codex DNA key metrics
Market Cap | 38.32M |
Enterprise value | N/A |
P/E | -0.72 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 2.49 |
Price/Book | -0.36 |
PEG ratio | N/A |
EPS | -1.29 |
Revenue | 30.00M |
EBITDA | -40.64M |
Income | -38.83M |
Revenue Q/Q | -16.64% |
Revenue Y/Y | 42.56% |
Profit margin | -342.92% |
Oper. margin | -329.08% |
Gross margin | 28.51% |
EBIT margin | -329.08% |
EBITDA margin | -135.47% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCodex DNA stock price history
Codex DNA stock forecast
Codex DNA financial statements
| Dec 2022 | 9.46M | -8.08M | -85.37% |
|---|---|---|---|
| Mar 2023 | 6.31M | -11.11M | -175.95% |
| Jun 2023 | 8.65M | -8.44M | -97.55% |
| Sep 2023 | 5.56M | -11.19M | -201.28% |
| 2022-03-22 | -0.37 | -0.43 |
|---|---|---|
| 2022-05-11 | -0.43 | -0.45 |
| 2022-08-09 | -0.51 | -0.5 |
| 2022-11-08 | -0.48 | -0.42 |
| Dec 2022 | 81362000 | 34.79M | 42.77% |
|---|---|---|---|
| Mar 2023 | 89162000 | 52.54M | 58.93% |
| Jun 2023 | 114526000 | 58.45M | 51.04% |
| Sep 2023 | 105029000 | 58.54M | 55.74% |
| Sep 2022 | -33.07M | -29.21M | 4.40M |
|---|---|---|---|
| Dec 2022 | 12.33M | 54.14M | -281K |
| Mar 2023 | -11.16M | 4.12M | -18K |
| Jun 2023 | 0 | 0 | 0 |
Codex DNA alternative data
| Aug 2023 | 212 |
|---|---|
| Sep 2023 | 212 |
| Oct 2023 | 212 |
| Nov 2023 | 212 |
| Dec 2023 | 212 |
| Jan 2024 | 212 |
| Feb 2024 | 212 |
| Mar 2024 | 212 |
| Apr 2024 | 212 |
| May 2024 | 212 |
| Jun 2024 | 212 |
| Jul 2024 | 212 |
Codex DNA other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2022 | 122516 | 0 |
| May 2023 | 0 | 4939 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | NELSON TODD ROBERT director, 10 perc.. | Common Stock | 2,575 | $2.83 | $7,277 | ||
Sale | GIBSON DANIEL GLENN officer: Chief Technology Officer | Common Stock | 1,190 | $2.83 | $3,363 | ||
Sale | CUTLER ROB officer: Chief Legal Officer | Common Stock | 1,174 | $2.83 | $3,318 | ||
Purchase | NELSON TODD ROBERT officer: Presiden.. | Common Stock | 122,516 | $1.56 | $191,493 | ||
Purchase | NORTHPOND VENTURES GP, LLC | Common Stock | 468,750 | $16 | $7,500,000 | ||
Purchase | HUNTER BRENT M. | Common Stock | 500 | $18.25 | $9,125 |
| Quarter | Transcript |
|---|---|
| Q3 2022 12 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 14 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 14 May 2022 | Q1 2022 Earnings Call Transcript |
| Q4 2021 22 Mar 2022 | Q4 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Todd R. Nelson (1967) Pres, Chief Executive Officer & Director | $735,780 |
Mr. Daniel G. Gibson (1977) Chief Technology Officer | $365,650 |
-
What's the price of Codex DNA stock today?
One share of Codex DNA stock can currently be purchased for approximately $1.3.
-
When is Codex DNA's next earnings date?
Unfortunately, Codex DNA's (DNAY) next earnings date is currently unknown.
-
Does Codex DNA pay dividends?
No, Codex DNA does not pay dividends.
-
How much money does Codex DNA make?
Codex DNA has a market capitalization of 38.32M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 148.44% to 27.44M US dollars. Codex DNA made a loss 48.42M US dollars in net income (profit) last year or -$0.42 on an earnings per share basis.
-
What is Codex DNA's stock symbol?
Codex DNA, Inc. is traded on the NASDAQ under the ticker symbol "DNAY".
-
What is Codex DNA's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Codex DNA?
Shares of Codex DNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Codex DNA's key executives?
Codex DNA's management team includes the following people:
- Dr. Todd R. Nelson Pres, Chief Executive Officer & Director(age: 58, pay: $735,780)
- Mr. Daniel G. Gibson Chief Technology Officer(age: 48, pay: $365,650)
-
How many employees does Codex DNA have?
As Jul 2024, Codex DNA employs 212 workers.
-
When Codex DNA went public?
Codex DNA, Inc. is publicly traded company for more then 4 years since IPO on 18 Jun 2021.
-
What is Codex DNA's official website?
The official website for Codex DNA is codexdna.com.
-
Where are Codex DNA's headquarters?
Codex DNA is headquartered at 9535 Waples Street, San Diego, CA.
-
How can i contact Codex DNA?
Codex DNA's mailing address is 9535 Waples Street, San Diego, CA and company can be reached via phone at 858 228 4115.
Codex DNA company profile:
Codex DNA, Inc.
codexdna.comExchange:
NASDAQ
Full time employees:
212
Industry:
Medical - Devices
Sector:
Healthcare
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
9535 Waples Street
San Diego, CA 92121-2993
San Diego, CA 92121-2993
CIK: 0001850079
ISIN: US1920031010
CUSIP: 192003101
